A Novel Drug Targeting Strategy for the Treatment of Inflammatory Bowel Disease: A Molecular Biopharmaceutical Approach

Project Information

TARGETIBDBYPLA2

Grant agreement ID: 277079

Project closed

Start date 1 May 2011

End date 30 April 2015

Funded under

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Total cost € 100 000,00

EU contribution € 100 000,00

Coordinated by

BEN-GURION UNIVERSITY OF THE NEGEV
Israel